Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents

E-ISSN： 1873-4286|11|4|489-509

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.4, 2005-02, pp. : 489-509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Inhibitors of Fatty Acid Synthase (FASN)-Catalyzed Endogenous Fatty Acid Biogenesis: A New Family of Anti-Cancer Agents?

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 483-494

Bentham Science Publishers

Access to resources Recommend Favorite

Promising Targets for Anti-Hepatitis C Virus Agents

Current Medicinal Chemistry, Vol. 18, Iss. 8, 2011-03 ,pp. : 1239-1244

Bentham Science Publishers

Access to resources Recommend Favorite

Naphthalimides and Azonafides as Promising Anti-Cancer Agents

Current Medicinal Chemistry, Vol. 16, Iss. 10, 2009-04 ,pp. : 1192-1213

Bentham Science Publishers

Access to resources Recommend Favorite

Platensimycin: A Promising Antimicrobial Targeting Fatty Acid Synthesis

Current Medicinal Chemistry, Vol. 15, Iss. 7, 2008-03 ,pp. : 705-710

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational anti-inflammatory agents for the treatment of ischaemic brain injury

By Wang Xinkang

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 4, 2005-04 ,pp. : 393-409

Informa Healthcare

Access to resources Recommend Favorite